AI assistant
Sending…
Adaptive Biotechnologies Corp — Director's Dealing 2022
Nov 2, 2022
31660_dirs_2022-11-01_9ce4c109-de99-4395-a781-875f871a44f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2022-11-01
Reporting Person: SOOD NITIN (Chief Commercial Officer, MRD)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-01 | Common Stock | S | 31066 | $8.00 | Disposed | 114505 | Direct |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
More from Adaptive Biotechnologies Corp
Annual Report
2026
Apr 24
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 4
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 6
Regulatory Filings
2026
Feb 5
Director's Dealing
2026
Feb 4